Follow-The-Filings

Security · featured owners

AMPH Amphastar Pharmaceuticals Ord

Health Care EQUITY Equity among managers we track

AMPH (Amphastar Pharmaceuticals Ord) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 5.02
8-K 8.01
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
8-K 8.01
8-K 1.01,9.01
8-K 5.02,9.01
8-K 2.02,9.01
10-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026
4 Period Sep 2, 2026
4 Period Aug 11, 2026
4 Period Aug 7, 2026
4 Period Jul 9, 2026
4 Period Jun 1, 2026 · 5 forms
4 Period Aug 19, 2024
4 Period Mar 15, 2026 · 4 forms
4 Period Mar 9, 2026 · 4 forms
4 Period Mar 6, 2026 · 4 forms
4 Period Mar 4, 2026 · 2 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $644.4M $731.97M $719.89M
Gross profit $351.12M $373.86M $356.06M
Gross margin * 54.5% 51.1% 49.5%
Net income $137.54M $159.52M $98.09M
Net margin * 21.3% 21.8% 13.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $489.6M $534.07M $636.02M
Total non-current assets * $1.02B $1.04B $0.993B
Total assets $1.51B $1.58B $1.63B
Total current liabilities $225.41M $173.76M $158.16M
Total non-current liabilities * $648.08M $671.41M $682.34M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $183.5M $213.39M $156.12M
Cash from investing -$649.12M -$124.93M -$70.33M
Cash from financing $454.09M -$80.95M -$67.42M
Net change in cash -$11.8M $7.31M $18.57M

ownership over time

filing count by report period · click a bar for that quarter’s holders

period archive